Pituitary homeobox 3 (PITX3)

Pituitary homeobox 3 (PITX3) is a homeodomain-containing transcription factor of the RIEG/PITX family, essential for the specification, differentiation, and maintenance of midbrain dopaminergic neurons, particularly those in the substantia nigra—neurons whose degeneration is seen in Parkinson’s disease[1][2][3][5]. PITX3 is also critically involved in early eye development, playing a fundamental role in lens formation and the maintenance of lens epithelial cell proliferation and fiber cell differentiation[1][3][5]. Mutations in PITX3 cause congenital disorders such as anterior segment mesenchymal dysgenesis and cataracts[1][3][5], and genetic variants have been linked to increased susceptibility to early-onset Parkinson’s disease[2][3]. No approved drugs directly target PITX3, but its pathway is of interest for disease-modifying strategies in Parkinson’s disease and neurodevelopmental disorders[2][5].

Other names

ASGD1ASMDASODCTPP4CTRCT11PTX3paired-like homeodomain transcription factor 3homeobox protein PITX3pituitary homeobox 3

Not applicable / No direct drug mechanism established; theoretically, modulation would affect dopaminergic neuron differentiation, TH (tyrosine hydroxylase) expression, or neuroprotection via neurotrophic factor regulation